Sorafenib after combination therapy with gemcitabine plus doxorubicine in patients with sarcomatoid renal cell Carcinoma: a prospective evaluation

BACKGROUND: Sarcomatoid renal cell cancer (RCC) is a distinct histological variant of RCC that is associated with rapid progression and a poor prognosis. The optimal treatment for patients with sarcomatoid RCC remains to be defined. Gemcitabine plus doxorubicine (GD) has shown some efficacy, however...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Staehler, M, Haseke, N, Roosen, A, Stadler, T, Bader, M, Siebels, M, Karl, A, Stief, CG
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BioMed Central 2010
Gaiak:
Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3351952/
https://ncbi.nlm.nih.gov/pubmed/20696639
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2047-783X-15-7-287
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak